Vaccinia FDA Approval History
FDA Approved: Yes (First approved May 2, 2005)
Brand name: Vaccinia
Generic name: vaccinia immune globulin intravenous (human)
Dosage form: Injection
Company: DynPort Vaccine Company LLC
Treatment for: Smallpox Vaccine Reaction
Vaccinia Immune Globulin Intravenous (Human) (VIGIV) indicated for the treatment of complications from smallpox vaccination
Development timeline for Vaccinia
| Date | Article |
|---|---|
| Feb 18, 2005 | Approval Vaccinia DynPort Vaccine Company LLC - Treatment for Complications of Smallpox Vaccination |
| Aug 3, 2004 | DVC Announces FDA Acceptance for Filing of Vaccinia Immune Globulin BLA |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
